Theravance Biopharma (TBPH) Earnings Date & Reports

Industry: @Pharmaceuticals Other

A.I. Advisor

published Earnings

TBPH is expected to report earnings to fall 44.26% to -18 cents per share on November 05

Theravance Biopharma TBPH Stock Earnings Reports

Q3'24

Est.

$-0.19

Q2'24

Missed

by $0.13

Q1'24

Beat

by $0.01

Q4'23

Missed

by $0.02

Q3'23

Beat

by $0.04

The last earnings report on August 05 showed earnings per share of -34 cents, missing the estimate of -20 cents. With 163.09K shares outstanding, the current market capitalization sits at 396.27M.

View a ticker or compare two or three

Compare

TBPH

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For TBPH
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for TBPH (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a developer of small molecule pharmaceutical products

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Pharmaceuticals Other

Address

Ugland House, South Church Street

Phone

+1 650 808-6000

Employees

Web

https://www.theravance.com